Delivery Order SPE2DE24DA017-SPE2D625F0HCZ
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 23, 2025, was awarded without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,665.20 for the Arthrex ACP Double Syringe System on April 24, 2025. This fixed-price contract with economic price adjustment carries an ultimate completion date of April 29, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain to support the government's orthopedic medical device needs,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $1,650 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 8, 2025, represents a task order issued under Arthrex's significant Indefinite Delivery Contract (IDC SPE2DE24D0020) valued at $471.0 million and spanning from June...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order, valued at $3,300, is scheduled for completion by September 9, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,250.00 for the Arthrex ACP Double Syringe System on September 15, 2025. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion on September 18, 2025, and will be performed at the company's Naples, FL facility. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F0HCZDelivery Order
Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The place of performance is located in Naples, FL 34108. This delivery order is issued under the Defense Logistics Agency's comprehensive IDC valued at $471 million, which runs through September 2029 and enables Veterans Affairs medical centers and Department of Defense facilities nationwide to procure Arthrex's orthopedic solutions. The ACP Double Syringe System is consistent with Arthrex's product portfolio of surgical instruments, implant systems, and specialized medical device sets designed to support orthopedic procedures for military personnel and veterans. To date, Arthrex has received over $550,000 in delivery orders under this IDC, demonstrating its established capability to support government healthcare systems with advanced medical technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/6/25 |